Dr. Chalhoub is a medical scientist who is passionate about bridging the gap between research and the medical practice. Dr. Chalhoub is a strong believer of using state of the art technologies to improve quality of care and diagnose diseases. His area of concentration is on osteoporosis and body composition with a special interest in understanding the effect of muscle-bone interaction on outcomes such as fractures. During his doctoral training, Didier’s research focused on “sarcopenia”, defined as the age-related loss of muscle mass and strength. Additionally, Didier worked as a research associate at the center for aging and population health (CAPH). He was primarily involved in a clinical trial to determine whether testosterone treatment of men aged 65 or older will improve their walking abilities, sexual function, energy levels, memory, low red blood cell counts, bone density, and muscle mass.
Currently, Didier is pursuing his passion at the National Institute on Aging (NIA), one of the 27 Institutes of the National Institutes of Health (NIH) and the leader in aging research. Because of his strong interest in education, Dr Chalhoub is also building a website that instructs research professionals and students on how to conduct epidemiological studies by assisting in the design, methodology, data analysis, and interpretation of results.
Dr. Dash is a senior scientific director at HemoShear. Prior to HemoShear, Dr. Dash conducted postdoctoral research at the Massachusetts Institute of Technology (MIT), where he had over nine years of experience working on the development and application of organotypic cell-based liver systems. Prior to joining MIT in 2001, Dr. Dash worked at Pfizer and Parke-Davis in Mumbai, India. Dr. Dash received his Ph.D. in Molecular Toxicology from MIT in 2007 and his M.D. (Residency equivalent) in Pharmacology from King Edward Memorial Hospital in Mumbai, India in 2000. He also received his M.B.B.S. (U.S. Medical Doctor equivalent) in 1995 from S.C.B. Medical College in Cuttack, India.
Dominik Duscher is fascinated by the exciting possibilities held by the emerging field of regenerative medicine and stem cell technology. Inspired by the perspective of combining basic research in the area of tissue and organ regeneration with clinical plastic and reconstructive surgery, Dr. Duscher decided to pursue a career as a surgeon-scientist.
Dominik also works as a postdoctoral fellow in Dr. Geoffrey Gurtner’s laboratory at the Division of Plastic Surgery at Stanford University. Dr. Duscher’s research investigations include characterizing mesenchymal stem cell populations using microfluidic technology and ultimately testing them within the setting of a biomimetic scaffold for the promotion of tissue regeneration and scarless wound healing. Translational research goals include: development of a stem cell seeded regenerative bandage capable of accelerating healing and preventing the onset of scarring and fibrosis in both acute and chronic wounds.
Dr. Moukamal is a Board Certified Internal Medicine physician, and a practicing clinician for more than 15 years. Dr. Moukamal serves as a Medical Director of a thriving Hospital Medicine program, in addition to other clinical and administrative leadership roles. His responsibilities include managing high performance health care teams, board of director appointments and participating on medical executive committees, building strategic alliances, and optimizing clinical workflow and patient safety.
Dr. Moukamal is also an active angel investor within a nationally-ranked professional angel investor group. Dr. Moukamal’s investment focus areas include: Electronic Health Records, mHealth, Medical Devices, Personal Health, Medical Elder Care and Corporate Wellness.